Viral Antigens Market
Viral Antigens Market Forecasts to 2032 - Global Analysis By Type (Native Antigens, Recombinant Antigens, Synthetic Antigens, Inactivated Antigen, Live Attenuated Antigens, and Other Types), Virus Type, Distribution Channel, Diagnostic Method, Application, End Users and By Geography
|
Years Covered |
2024-2032 |
|
Estimated Year Value (2025) |
US $235.40 BN |
|
Projected Year Value (2032) |
US $464.60 BN |
|
CAGR (2025-2032) |
10.2% |
|
Regions Covered |
North America, Europe, Asia Pacific, South America, and Middle East & Africa |
|
Countries Covered |
US, Canada, Mexico, Germany, UK, Italy, France, Spain, Japan, China, India, Australia, New Zealand, South Korea, Rest of Asia Pacific, South America, Argentina, Brazil, Chile, Middle East & Africa, Saudi Arabia, UAE, Qatar, and South Africa |
|
Largest Market |
Asia Pacific |
|
Highest Growing Market |
North America |
According to Stratistics MRC, the Global Viral Antigens Market is accounted for $235.40 billion in 2025 and is expected to reach $464.60 billion by 2032 growing at a CAGR of 10.2% during the forecast period. Viral antigens are molecules derived from viruses that trigger an immune response in the body. These antigens, typically proteins or glycoproteins found on the surface of the virus, are recognized by the immune system as foreign, prompting the production of antibodies. Viral antigens play a crucial role in diagnostic tests, vaccine development, and research, as they help detect viral infections, stimulate immunity, and contribute to understanding viral behaviors and interactions with the immune system.
According to the National Centre for Biotechnology Information (NCBI), 64.44% virus-specific B cell epitopes are situated in viral antigens that remain enclosed within viral particles or host cells.
Market Dynamics:
Driver:
Increasing prevalence of viral infections
The demand for precise diagnoses and efficient antigen-based treatments is increasing as novel strains appear all over the world. The significance of antigen-based diagnostics has been brought to light by viral illnesses such as COVID-19, hepatitis, and influenza. The need for viral antigen research and development is further highlighted by the rising incidence of zoonotic illnesses. Furthermore, the development of more potent antigens to fight viral outbreaks has been made possible by technological breakthroughs. These factors collectively contribute to the increased demand for viral antigens worldwide.
Restraint:
High costs of antigen production
The manufacturing process for antigens involves expensive technologies like recombinant DNA and monoclonal antibodies. Additionally, the need for specialized facilities and skilled professionals adds to the production cost. Regulatory requirements for quality control and safety testing further increase expenses for manufacturers. Small-scale companies and developing nations face financial challenges in antigen production due to these costs. This limitation hampers widespread accessibility and affordability of viral antigens across various regions.
Opportunity:
Growing focus on preventive healthcare
Governments and organizations worldwide are emphasizing vaccination programs to curb the spread of viral infections. Antigen-based vaccines play a crucial role in achieving preventive healthcare objectives. Moreover, advancements in immunology and antigen technologies are driving innovation in vaccine development. Public awareness about preventive measures, such as regular screening and vaccination, is boosting market demand. This trend creates immense potential for companies to expand their antigen product portfolios and cater to global healthcare needs.
Threat:
Limited Availability of Certain Viral Antigens
Some antigens are difficult to source or produce due to the complexity of viral structures. This limitation affects the timely development of diagnostic tests and vaccines for emerging viruses. For instance, rare viral strains or rapidly mutating viruses may lack suitable antigens for research. Additionally, supply chain disruptions and geopolitical factors can affect antigen availability in certain regions. These issues threaten the ability of manufacturers to meet the growing demand for viral antigens.
Covid-19 Impact:
The COVID-19 pandemic has had a profound impact on the Viral Antigens Market. It accelerated the development and adoption of antigen-based diagnostic tests to detect the virus. The high demand for COVID-19 vaccines further highlighted the importance of viral antigens. Post-pandemic, the focus on healthcare preparedness and vaccine development remains strong. The pandemic emphasized the role of viral antigens in addressing global health challenges and driving market growth.
The native antigens segment is expected to be the largest during the forecast period
The native antigens segment is expected to account for the largest market share during the forecast period, due to their natural composition, which closely mimics the structure of the virus, providing accurate immune responses. Their use in diagnostics and vaccine development is crucial for detecting infections and stimulating effective immunity. Additionally, native antigens are preferred in vaccine formulations for their ability to produce robust and long-lasting immunity, increasing demand across research, diagnostics, and therapeutic applications.
The therapeutic use segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the therapeutic use segment is predicted to witness the highest growth rate, driven by their potential to enhance immunotherapies and antiviral treatments. By stimulating targeted immune responses, viral antigens can aid in treating chronic viral infections or boosting the body's defense mechanisms. The increasing focus on personalized medicine and the development of novel treatments for viral diseases further propels the demand for viral antigens in therapeutic applications, improving patient outcomes.
Region with largest share:
During the forecast period, the Asia Pacific region is expected to hold the largest market share, due to the increasing prevalence of viral infections, such as hepatitis, influenza, and COVID-19. Rapid urbanization, improving healthcare infrastructure, and growing investments in research and diagnostics are further fueling market growth. Additionally, government initiatives promoting vaccination programs and diagnostic testing, along with the rising awareness of viral diseases, are significantly boosting the demand for viral antigens across the region.
Region with highest CAGR:
Over the forecast period, the Europe region is anticipated to exhibit the highest CAGR, owing to the high prevalence of viral infections, including influenza, HIV, and COVID-19, which increases the demand for diagnostic tests and vaccines. Advanced healthcare infrastructure, extensive research and development in biotechnology, and strong government support for public health initiatives contribute to market growth. Furthermore, rising awareness of viral diseases and the need for rapid diagnostics are key factors driving demand for viral antigens in the region.
Key players in the market
Some of the key players in Viral Antigens Market include Creative Diagnostics, Bio-Rad Laboratories, Inc., Microbix Biosystems Inc., Aalto Bio Reagents, Prospec-Tany Technogene Ltd., Sino Biological, Inc., Meridian Bioscience, F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific, Inc., Abbott, Cepheid, The Native Antigen Company, DiaSorin S.p.A, Quidel Corporation, and Randox Laboratories Ltd.
Key Developments:
In February 2025, Shedd Aquarium and global healthcare company Abbott are announcing one of Shedd’s largest corporate gifts in recent history a $10 million pledge from Abbott and Abbott's philanthropic foundation, Abbott Fund. The investment cements the longstanding partnership between Shedd, Abbott, and Abbott Fund to enrich the cultural, educational and environmental fabric of Chicago and spark passion for protecting the ocean environment.
In November 2024, Microbix Biosystems Inc. announces that key opinion leader (“KOL”) collaborators are presenting results of a Microbix Quality Assessment Product (“QAP™”) for controlling testing for high-risk types of Human Papilloma Virus (“HPV”) at the 36th annual International Papillomavirus Conference (“IPVC”) taking place in Edinburgh, Scotland.
Types Covered:
• Native Antigens
• Recombinant Antigens
• Synthetic Antigens
• Inactivated Antigen
• Live Attenuated Antigens
• Other Types
Virus Types Covered:
• Human Immunodeficiency Virus (HIV)
• Influenza Virus
• Hepatitis Virus
• COVID-19 (SARS-CoV-2)
• Herpes Simplex Virus (HSV)
• Other Virus Types
Distribution Channels Covered:
• Direct Sales
• Online Sales
• Third-Party Distributors
• Retail Pharmacies
Diagnostic Methods Covered:
• Antigen-based Diagnostic Kits
• Immunoperoxidase Staining
• Immunoassays
• Hemagglutination
• Radioimmunoassay (RIA)
• Immunofluorescence
• Electron Microscopy
Applications Covered:
• Diagnostics
• Vaccine Development
• Research and Development
• Therapeutic Use
• Other Applications
End Users Covered:
• Research and Diagnostic Laboratories
• Pharmaceutical and Biotechnology Companies
• Hospitals
• Academic and Government Research Institutes
• Veterinary Clinics
• Other End Users
Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o South Korea
o Rest of Asia Pacific
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
Table of Contents
1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Application Analysis
3.7 End User Analysis
3.8 Emerging Markets
3.9 Impact of Covid-19
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Viral Antigens Market, By Type
5.1 Introduction
5.2 Native Antigens
5.3 Recombinant Antigens
5.4 Synthetic Antigens
5.5 Inactivated Antigen
5.6 Live Attenuated Antigens
5.7 Other Types
6 Global Viral Antigens Market, By Virus Type
6.1 Introduction
6.2 Human Immunodeficiency Virus (HIV)
6.3 Influenza Virus
6.4 Hepatitis Virus
6.5 COVID-19 (SARS-CoV-2)
6.6 Herpes Simplex Virus (HSV)
6.7 Other Virus Types
7 Global Viral Antigens Market, By Distribution Channel
7.1 Introduction
7.2 Direct Sales
7.3 Online Sales
7.4 Third-Party Distributors
7.5 Retail Pharmacies
8 Global Viral Antigens Market, By Diagnostic Method
8.1 Introduction
8.2 Antigen-based Diagnostic Kits
8.3 Immunoperoxidase Staining
8.4 Immunoassays
8.5 Hemagglutination
8.6 Radioimmunoassay (RIA)
8.7 Immunofluorescence
8.8 Electron Microscopy
9 Global Viral Antigens Market, By Application
9.1 Introduction
9.2 Diagnostics
9.2.1 Viral Detection Tests
9.2.2 Serology Tests
9.2.3 Polymerase Chain Reaction Assays (PCR)
9.3 Vaccine Development
9.4 Research and Development
9.5 Therapeutic Use
9.6 Other Applications
10 Global Viral Antigens Market, By End User
10.1 Introduction
10.2 Research and Diagnostic Laboratories
10.3 Pharmaceutical and Biotechnology Companies
10.4 Hospitals
10.5 Academic and Government Research Institutes
10.6 Veterinary Clinics
10.7 Other End Users
11 Global Viral Antigens Market, By Geography
11.1 Introduction
11.2 North America
11.2.1 US
11.2.2 Canada
11.2.3 Mexico
11.3 Europe
11.3.1 Germany
11.3.2 UK
11.3.3 Italy
11.3.4 France
11.3.5 Spain
11.3.6 Rest of Europe
11.4 Asia Pacific
11.4.1 Japan
11.4.2 China
11.4.3 India
11.4.4 Australia
11.4.5 New Zealand
11.4.6 South Korea
11.4.7 Rest of Asia Pacific
11.5 South America
11.5.1 Argentina
11.5.2 Brazil
11.5.3 Chile
11.5.4 Rest of South America
11.6 Middle East & Africa
11.6.1 Saudi Arabia
11.6.2 UAE
11.6.3 Qatar
11.6.4 South Africa
11.6.5 Rest of Middle East & Africa
12 Key Developments
12.1 Agreements, Partnerships, Collaborations and Joint Ventures
12.2 Acquisitions & Mergers
12.3 New Product Launch
12.4 Expansions
12.5 Other Key Strategies
13 Company Profiling
13.1 Creative Diagnostics
13.2 Bio-Rad Laboratories, Inc.
13.3 Microbix Biosystems Inc.
13.4 Aalto Bio Reagents
13.5 Prospec-Tany Technogene Ltd.
13.6 Sino Biological, Inc.
13.7 Meridian Bioscience
13.8 F. Hoffmann-La Roche Ltd
13.9 Thermo Fisher Scientific, Inc.
13.10 Abbott
13.11 Cepheid
13.12 The Native Antigen Company
13.13 DiaSorin S.p.A
13.14 Quidel Corporation
13.15 Randox Laboratories Ltd.
List of Tables
1 Global Viral Antigens Market Outlook, By Region (2024-2032) ($MN)
2 Global Viral Antigens Market Outlook, By Type (2024-2032) ($MN)
3 Global Viral Antigens Market Outlook, By Native Antigens (2024-2032) ($MN)
4 Global Viral Antigens Market Outlook, By Recombinant Antigens (2024-2032) ($MN)
5 Global Viral Antigens Market Outlook, By Synthetic Antigens (2024-2032) ($MN)
6 Global Viral Antigens Market Outlook, By Inactivated Antigen (2024-2032) ($MN)
7 Global Viral Antigens Market Outlook, By Live Attenuated Antigens (2024-2032) ($MN)
8 Global Viral Antigens Market Outlook, By Other Types (2024-2032) ($MN)
9 Global Viral Antigens Market Outlook, By Virus Type (2024-2032) ($MN)
10 Global Viral Antigens Market Outlook, By Human Immunodeficiency Virus (HIV) (2024-2032) ($MN)
11 Global Viral Antigens Market Outlook, By Influenza Virus (2024-2032) ($MN)
12 Global Viral Antigens Market Outlook, By Hepatitis Virus (2024-2032) ($MN)
13 Global Viral Antigens Market Outlook, By COVID-19 (SARS-CoV-2) (2024-2032) ($MN)
14 Global Viral Antigens Market Outlook, By Herpes Simplex Virus (HSV) (2024-2032) ($MN)
15 Global Viral Antigens Market Outlook, By Other Virus Types (2024-2032) ($MN)
16 Global Viral Antigens Market Outlook, By Distribution Channel (2024-2032) ($MN)
17 Global Viral Antigens Market Outlook, By Direct Sales (2024-2032) ($MN)
18 Global Viral Antigens Market Outlook, By Online Sales (2024-2032) ($MN)
19 Global Viral Antigens Market Outlook, By Third-Party Distributors (2024-2032) ($MN)
20 Global Viral Antigens Market Outlook, By Retail Pharmacies (2024-2032) ($MN)
21 Global Viral Antigens Market Outlook, By Diagnostic Method (2024-2032) ($MN)
22 Global Viral Antigens Market Outlook, By Antigen-based Diagnostic Kits (2024-2032) ($MN)
23 Global Viral Antigens Market Outlook, By Immunoperoxidase Staining (2024-2032) ($MN)
24 Global Viral Antigens Market Outlook, By Immunoassays (2024-2032) ($MN)
25 Global Viral Antigens Market Outlook, By Hemagglutination (2024-2032) ($MN)
26 Global Viral Antigens Market Outlook, By Radioimmunoassay (RIA) (2024-2032) ($MN)
27 Global Viral Antigens Market Outlook, By Immunofluorescence (2024-2032) ($MN)
28 Global Viral Antigens Market Outlook, By Electron Microscopy (2024-2032) ($MN)
29 Global Viral Antigens Market Outlook, By Application (2024-2032) ($MN)
30 Global Viral Antigens Market Outlook, By Diagnostics (2024-2032) ($MN)
31 Global Viral Antigens Market Outlook, By Viral Detection Tests (2024-2032) ($MN)
32 Global Viral Antigens Market Outlook, By Serology Tests (2024-2032) ($MN)
33 Global Viral Antigens Market Outlook, By Polymerase Chain Reaction Assays (PCR) (2024-2032) ($MN)
34 Global Viral Antigens Market Outlook, By Vaccine Development (2024-2032) ($MN)
35 Global Viral Antigens Market Outlook, By Research and Development (2024-2032) ($MN)
36 Global Viral Antigens Market Outlook, By Therapeutic Use (2024-2032) ($MN)
37 Global Viral Antigens Market Outlook, By Other Applications (2024-2032) ($MN)
38 Global Viral Antigens Market Outlook, By End User (2024-2032) ($MN)
39 Global Viral Antigens Market Outlook, By Research and Diagnostic Laboratories (2024-2032) ($MN)
40 Global Viral Antigens Market Outlook, By Pharmaceutical and Biotechnology Companies (2024-2032) ($MN)
41 Global Viral Antigens Market Outlook, By Hospitals (2024-2032) ($MN)
42 Global Viral Antigens Market Outlook, By Academic and Government Research Institutes (2024-2032) ($MN)
43 Global Viral Antigens Market Outlook, By Veterinary Clinics (2024-2032) ($MN)
44 Global Viral Antigens Market Outlook, By Other End Users (2024-2032) ($MN)
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.
List of Figures
RESEARCH METHODOLOGY
We at ‘Stratistics’ opt for an extensive research approach which involves data mining, data validation, and data analysis. The various research sources include in-house repository, secondary research, competitor’s sources, social media research, client internal data, and primary research.
Our team of analysts prefers the most reliable and authenticated data sources in order to perform the comprehensive literature search. With access to most of the authenticated data bases our team highly considers the best mix of information through various sources to obtain extensive and accurate analysis.
Each report takes an average time of a month and a team of 4 industry analysts. The time may vary depending on the scope and data availability of the desired market report. The various parameters used in the market assessment are standardized in order to enhance the data accuracy.
Data Mining
The data is collected from several authenticated, reliable, paid and unpaid sources and is filtered depending on the scope & objective of the research. Our reports repository acts as an added advantage in this procedure. Data gathering from the raw material suppliers, distributors and the manufacturers is performed on a regular basis, this helps in the comprehensive understanding of the products value chain. Apart from the above mentioned sources the data is also collected from the industry consultants to ensure the objective of the study is in the right direction.
Market trends such as technological advancements, regulatory affairs, market dynamics (Drivers, Restraints, Opportunities and Challenges) are obtained from scientific journals, market related national & international associations and organizations.
Data Analysis
From the data that is collected depending on the scope & objective of the research the data is subjected for the analysis. The critical steps that we follow for the data analysis include:
- Product Lifecycle Analysis
- Competitor analysis
- Risk analysis
- Porters Analysis
- PESTEL Analysis
- SWOT Analysis
The data engineering is performed by the core industry experts considering both the Marketing Mix Modeling and the Demand Forecasting. The marketing mix modeling makes use of multiple-regression techniques to predict the optimal mix of marketing variables. Regression factor is based on a number of variables and how they relate to an outcome such as sales or profits.
Data Validation
The data validation is performed by the exhaustive primary research from the expert interviews. This includes telephonic interviews, focus groups, face to face interviews, and questionnaires to validate our research from all aspects. The industry experts we approach come from the leading firms, involved in the supply chain ranging from the suppliers, distributors to the manufacturers and consumers so as to ensure an unbiased analysis.
We are in touch with more than 15,000 industry experts with the right mix of consultants, CEO's, presidents, vice presidents, managers, experts from both supply side and demand side, executives and so on.
The data validation involves the primary research from the industry experts belonging to:
- Leading Companies
- Suppliers & Distributors
- Manufacturers
- Consumers
- Industry/Strategic Consultants
Apart from the data validation the primary research also helps in performing the fill gap research, i.e. providing solutions for the unmet needs of the research which helps in enhancing the reports quality.
For more details about research methodology, kindly write to us at info@strategymrc.com
Frequently Asked Questions
In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.
Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.
All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
We have 3 different licensing options available in electronic format.
- Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
- 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
- Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.
All our reports are typically be emailed to you as an attachment.
To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards.
We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.
Request Customization
We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.
WHY CHOOSE US ?
Assured Quality
Best in class reports with high standard of research integrity
24X7 Research Support
Continuous support to ensure the best customer experience.
Free Customization
Adding more values to your product of interest.
Safe & Secure Access
Providing a secured environment for all online transactions.
Trusted by 600+ Brands
Serving the most reputed brands across the world.
